발행물
컨퍼런스
Experimental Biology 2011
2011
,
Effects of the CYP2D6 genotypes on the pharmacokinetics of atomoxetine
2011 ASCPT Annual Meeting
Effects of clopidogrel, CYP2B6 and CYP2C19 inhibitors, on the pharmacokinetics of sibutramine and its active metabolites
The 16th World Congress of Basic and Clinical Pharmacology
2010
Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of ezetimibe and its glucuronide in healthy subjects
CYP2D6 genetic polymorphism has an impact on the pharmacokinetics of carvedilol in Korean subjects
CYP2C9*3 and *13 alleles significantly affected the pharmacokinetics of celecoxib in healthy Korean subjects